IBDEI2WL ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46311,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Bilateral
 ;;^UTILITY(U,$J,358.3,46311,1,4,0)
 ;;=4^H40.1231
 ;;^UTILITY(U,$J,358.3,46311,2)
 ;;=^5005768
 ;;^UTILITY(U,$J,358.3,46312,0)
 ;;=H40.1233^^176^2305^20
 ;;^UTILITY(U,$J,358.3,46312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46312,1,3,0)
 ;;=3^Low-Tension Glaucoma,Severe,Bilateral
 ;;^UTILITY(U,$J,358.3,46312,1,4,0)
 ;;=4^H40.1233
 ;;^UTILITY(U,$J,358.3,46312,2)
 ;;=^5005770
 ;;^UTILITY(U,$J,358.3,46313,0)
 ;;=H40.011^^176^2305^21
 ;;^UTILITY(U,$J,358.3,46313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46313,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,Low Risk,Right Eye
 ;;^UTILITY(U,$J,358.3,46313,1,4,0)
 ;;=4^H40.011
 ;;^UTILITY(U,$J,358.3,46313,2)
 ;;=^5005724
 ;;^UTILITY(U,$J,358.3,46314,0)
 ;;=H40.012^^176^2305^22
 ;;^UTILITY(U,$J,358.3,46314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46314,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,Low Risk,Left Eye
 ;;^UTILITY(U,$J,358.3,46314,1,4,0)
 ;;=4^H40.012
 ;;^UTILITY(U,$J,358.3,46314,2)
 ;;=^5005725
 ;;^UTILITY(U,$J,358.3,46315,0)
 ;;=H59.41^^176^2305^25
 ;;^UTILITY(U,$J,358.3,46315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46315,1,3,0)
 ;;=3^Blebitis,Stage 1
 ;;^UTILITY(U,$J,358.3,46315,1,4,0)
 ;;=4^H59.41
 ;;^UTILITY(U,$J,358.3,46315,2)
 ;;=^5006426
 ;;^UTILITY(U,$J,358.3,46316,0)
 ;;=H40.1111^^176^2305^6
 ;;^UTILITY(U,$J,358.3,46316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46316,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,46316,1,4,0)
 ;;=4^H40.1111
 ;;^UTILITY(U,$J,358.3,46316,2)
 ;;=^5138537
 ;;^UTILITY(U,$J,358.3,46317,0)
 ;;=H40.1121^^176^2305^7
 ;;^UTILITY(U,$J,358.3,46317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46317,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Mild Stage,Left Eye
 ;;^UTILITY(U,$J,358.3,46317,1,4,0)
 ;;=4^H40.1121
 ;;^UTILITY(U,$J,358.3,46317,2)
 ;;=^5138542
 ;;^UTILITY(U,$J,358.3,46318,0)
 ;;=H40.013^^176^2305^4
 ;;^UTILITY(U,$J,358.3,46318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46318,1,3,0)
 ;;=3^Glaucoma Suspect,Low Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,46318,1,4,0)
 ;;=4^H40.013
 ;;^UTILITY(U,$J,358.3,46318,2)
 ;;=^5005726
 ;;^UTILITY(U,$J,358.3,46319,0)
 ;;=H40.023^^176^2305^5
 ;;^UTILITY(U,$J,358.3,46319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46319,1,3,0)
 ;;=3^Glaucoma Suspect,High Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,46319,1,4,0)
 ;;=4^H40.023
 ;;^UTILITY(U,$J,358.3,46319,2)
 ;;=^5005730
 ;;^UTILITY(U,$J,358.3,46320,0)
 ;;=H40.1132^^176^2305^11
 ;;^UTILITY(U,$J,358.3,46320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46320,1,3,0)
 ;;=3^Primary Open-Angle Gluacoma,Mod Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,46320,1,4,0)
 ;;=4^H40.1132
 ;;^UTILITY(U,$J,358.3,46320,2)
 ;;=^5138548
 ;;^UTILITY(U,$J,358.3,46321,0)
 ;;=H40.1232^^176^2305^19
 ;;^UTILITY(U,$J,358.3,46321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46321,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mod,Bilateral
 ;;^UTILITY(U,$J,358.3,46321,1,4,0)
 ;;=4^H40.1232
 ;;^UTILITY(U,$J,358.3,46321,2)
 ;;=^5005769
 ;;^UTILITY(U,$J,358.3,46322,0)
 ;;=H40.1113^^176^2305^12
 ;;^UTILITY(U,$J,358.3,46322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46322,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Sev Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,46322,1,4,0)
 ;;=4^H40.1113
 ;;^UTILITY(U,$J,358.3,46322,2)
 ;;=^5138539
